6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Anxiety Disorders: Advances in Therapy and Research
High prevalence and functional impairment make anxiety disorders a major concern in psychiatric care. With anxiety disorders: advances in therapy and research, new pathways are being explored beyond conventional exposure-based treatments. Advances in neurobiology have revealed how fear circuitry and stress responses can be modulated through therapies such as mindfulness-based interventions, EMDR, and even psychedelic-assisted therapy. Emerging pharmacologic agents offer rapid symptom relief with fewer side effects. Technological tools like virtual reality are enhancing the delivery of exposure therapy, especially for social and phobic anxiety. Combining neuroscience, psychotherapy, and tech-based delivery systems fosters earlier intervention, higher engagement, and sustained treatment outcomes.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States